| 1. |
?Bayraktar UD, Bayraktar S, Rocha-Lima CM. Molecular basis and management of gastrointestinal stromal tumors. World J Gastroenterol, 2010, 16(22): 2726-2734.
|
| 2. |
DeMatteo RP, Shah A, Fong Y,et al. Results of hepatic resection for sarcoma metastatic to liver. Ann Surg, 2001, 234(4): 540-547.
|
| 3. |
Pawlik TM, Vauthey JN, Abdalla EK,et al. Results of a single-center experience with resection and ablation for sarcoma metastatic to the liver. Arch Surg, 2006, 141(6): 537-543.
|
| 4. |
Gold JS, van der Zwan SM, G?nen M,et al. Outcome of metastatic GIST in the era before tyrosine kinase inhibitors. Ann Surg Oncol, 2007, 14(1): 134-142.
|
| 5. |
Roberts PJ, Eisenberg B. Clinical presentation of gastrointestinal stromal tumors and treatment of operable disease. Eur J Cancer, 2002, 38 Suppl 5: S37-S38.
|
| 6. |
Dematteo RP, Maki RG, Antonescu C,et al. Targeted molecular therapy for cancer: the application of STI571 to gastrointestinal stromal tumor. Curr Probl Surg, 2003, 40(3): 144-193.
|
| 7. |
Turley RS, Peng PD, Reddy SK,et al. Hepatic resection for metastatic gastrointestinal stromal tumors in the tyrosine kinase inhibitor era. Cancer, 2012, 118(14): 3571-3578.
|
| 8. |
Seesing MF, Tielen R, van Hillegersberg R,et al. Resection of liver metastases in patients with gastrointestinal stromal tumors in the imatinib era: A nationwide retrospective study. Eur J Surg Oncol, 2016, 42(9): 1407-1413.
|
| 9. |
An HJ, Ryu MH, Ryoo BY,et al. The effects of surgical cytoreduction prior to imatinib therapy on the prognosis of patients with advanced GIST. Ann Surg Oncol, 2013, 20(13): 4212-4218.
|
| 10. |
Sym SJ, Ryu MH, Lee JL,et al. Surgical intervention following imatinib treatment in patients with advanced gastrointestinal stromal tumors (GISTs). J Surg Oncol, 2008, 98(1): 27-33.
|
| 11. |
Cananzi FC, Belgaumkar A, Lorenzi B,et al. Liver surgery in the multidisciplinary management of gastrointestinal stromal tumor. ANZ J Surg, 2014, 84(12): 937-942.
|
| 12. |
中華醫學會外科學分化胃腸外科學組. 胃腸間質瘤規范化外科治療專家共識. 中國實用外科雜志, 2015, 35(6): 593-597.
|
| 13. |
Yamanaka T, Takaki H, Nakatsuka A,et al. Radiofrequency ablation for liver metastasis from gastrointestinal stromal tumor. Vasc Interv Radiol, 2013, 24(3): 341-346.
|
| 14. |
Jarz?bek M, Jargie??o T, Wolski A,et al. Drug-eluting microspheres transarterial chemoembolization (DEM TACE) in patients with liver metastases. Pol J Radiol, 2011, 76(3): 26-32.
|
| 15. |
Kang YK, Ryu MH, Yoo C,et al. Resumption of imatinib to control metastatic or unresectable gastrointestinal stromal tumours after failure of imatinib and sunitinib (RIGHT): a randomised, placebo-controlled, phase 3 trial. Lancet Oncol, 2013, 14(12): 1175-1182.
|
1/5
WeChat